Science Explorer Interactive view Map
Company · Otelfingen · Switzerland

Philochem (Switzerland)

philochem.chROR OpenAlex
Research works
110
▲ 56% vs 2013–17
Citations
3.8k
34.4 per fractional work
Top-10% rate
21.4%
record average 16.5%
Open access
50%
world 28%

Not ranked overall: Philochem (Switzerland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.07× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.78× its world share, 7 worksBiochemistry, Geneti…Immunology and Microbiology: 4.24× its world share, 1 worksImmunology and Micro…Neuroscience: 1.56× its world share, 1 worksNeuroscienceChemistry: 3.32× its world share, 2 worksChemistryComputer Science: 0.03× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 0.09× its world share, 0 worksEarth and Planetary …Engineering: 0.14× its world share, 1 worksEngineeringEnvironmental Science: 0.06× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.49× its world share, 1 worksMaterials ScienceMedicine: 3.27× its world share, 21 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.2×. Every wedge is a field page.

Who are the top researchers at Philochem (Switzerland)?

Ranked on the composite score, Samuele Cazzamalli and Emanuele Puca lead among researchers whose main affiliation is Philochem (Switzerland).

  1. 1 Samuele Cazzamalli Switzerland · #1,172,939 worldwide 32 citations · 20 works
  2. 2 Emanuele Puca Switzerland · #1,433,955 worldwide 16 citations · 15 works
All ranked researchers at Philochem (Switzerland)

Which keywords describe research at Philochem (Switzerland)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: PET Imaging, Cancer Therapy, Tumor Microenvironment, Immunotherapy, Angiogenesis, Fibroblast Activation Protein, Immunosuppression and Glycosylation.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 30 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 30 words, with their numbers
  1. PET Imaging8▲ 148×3 topics
  2. Cancer Therapy7▲ 34×5 topics
  3. Tumor Microenvironment6▲ 42×3 topics
  4. Immunotherapy6▲ 25×10 topics
  5. Angiogenesis6▲ 53×5 topics
  6. Fibroblast Activation Protein5▲ 338×1 topic
  7. Immunosuppression5▲ 164×1 topic
  8. Glycosylation4▲ 101×3 topics
  9. Targeted Therapy4▲ 50×2 topics
  10. Cancer Immunotherapy4▲ 71×2 topics
  11. Cancer Treatment4▲ 46×2 topics
  12. Monoclonal Antibodies3▲ 111×2 topics
  13. Radioimmunotherapy3▲ 362×1 topic
  14. Radiopharmaceuticals3▲ 362×1 topic
  15. Therapeutic Antibodies3▲ 142×2 topics
  16. Antibody Engineering3▲ 178×1 topic
  17. Fc Receptors3▲ 178×1 topic
  18. Tumor Regression3▲ 88×2 topics
  19. Lymphoma3▲ 55×2 topics
  20. CAR T Cells3▲ 118×1 topic
  21. Chimeric Antigen Receptor3▲ 118×1 topic
  22. Drug Discovery2▲ 28×4 topics
  23. Foldamers1▲ 125×1 topic
  24. Nanoparticles1▲ 3.3×4 topics
  25. Peptide Synthesis1▲ 125×1 topic
  26. Genetic Mutations1▲ 9.2×4 topics
  27. Tumor Targeting1▲ 22×3 topics
  28. Cancer1▲ 2.6×5 topics
  29. Inflammation1▲ 1.74×7 topics
  30. Metastasis1▲ 9.2×5 topics

Which research topics does Philochem (Switzerland) publish most on?

By volume in 2022–2025: Peptidase Inhibition and Analysis, Radiopharmaceutical Chemistry and Applications, Monoclonal and Polyclonal Antibodies Research and CAR-T cell therapy research.

Peptidase Inhibition and…5Peptidase Inhibition and Analysis: 5 fractional worksRadiopharmaceutical Chemistry and Applications: 3 fractional worksMonoclonal and Polyclonal Antibodies Research: 3 fractional worksCAR-T cell therapy resea…3CAR-T cell therapy research: 3 fractional worksChemical Synthesis and A…1Chemical Synthesis and Analysis: 1 fractional worksNeuropeptides and Animal Physiology: 1 fractional worksUbiquitin and proteasome pathways: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksCancer, Hypoxia, and Metabolism: 1 fractional worksImmunotherapy and Immune Responses: 1 fractional works
OncologyRadiology, Nuclear Medicine and ImagingMolecular BiologyCellular and Molecular Neuroscience2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Peptidase Inhibition and Analysis Oncology 5 works
  2. 2 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 3 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 3 works
  4. 4 CAR-T cell therapy research Oncology 3 works
  5. 5 Chemical Synthesis and Analysis Molecular Biology 1 works
  6. 6 Neuropeptides and Animal Physiology Cellular and Molecular Neuroscience 1 works
  7. 7 Ubiquitin and proteasome pathways Molecular Biology 1 works
  8. 8 Cancer Immunotherapy and Biomarkers Oncology 1 works
  9. 9 Cancer, Hypoxia, and Metabolism Cancer Research 1 works
  10. 10 Immunotherapy and Immune Responses Immunology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available50.4%not open49.6%

World: 28% of research is openly available.

with international co-authors41.2%domestic only58.8%

World: 19% is written across borders.

How has Philochem (Switzerland)'s research output changed?

Output in 2018–2022 was 56% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.